Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
Merck & Co. Inc.
The first drug for NASH liver disease is here, with more to come
3D illustration of a human liver organ. magic mine | iStock | fake images Do you think a friend or…
What's next in Medicare drug price negotiations?
Activists protest prescription drug pricing outside the US Department of Health and Human Services building in Washington, DC, on October…
Gene Therapies for Sickle Cell Casgevy Lyfgenia Insurance Cost Issues
Patient's blood sample tested positive for sickle cell anemia. Kitsawet Saethao | Stock | fake images The approval of two…
Moderna (MRNA) Earnings in Q4 2023
Nikos Pekiaridis | Nurfoto | fake images modern It posted a surprise quarterly profit on Thursday, driven in part by…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
CEOs of Merck, J&J and Bristol Myers Squibb face Senate hearing on drug prices
Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey about issuing subpoenas for drug company CEOs…
J&J, Merck and Bristol Myers Squibb on the bench
Do you think a friend or colleague should receive this newsletter? Share this link with them to register. Good afternoon!…
Merck (MRK) 2023 Fourth Quarter Earnings Report
The Merck & Co. logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York…
Fourth-quarter earnings set to be best of 2023
Traders work at the New York Stock Exchange (NYSE) in New York City, USA, on February 1, 2024. Brendan McDermid…